Evidence map›Paper›PMID 36367637›Full record

ReviewCurrent HIV/AIDS reports2022

Defining the Global Research and Programmatic Agenda and Priority Actions for Voluntary Medical Male Circumcision for HIV Prevention.

Megan E Peck, Todd Lucas, Katherine S Ong, Jonathan M Grund, Stephanie Davis, Aisha Yansaneh, Valerian L Kiggundu, Anne G Thomas, Kelly Curran, Catharine Laube and 4 more

Open access · hybridAbstract readReview
In one paragraph

Review in Current HIV/AIDS reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Megan E PeckDivision of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention, 3 Corporate Blvd NE, US1-1, Atlanta, GA, 30329, USA. okv4@cdc.gov.
Todd LucasDivision of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention, 3 Corporate Blvd NE, US1-1, Atlanta, GA, 30329, USA.
Katherine S OngDivision of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention, 3 Corporate Blvd NE, US1-1, Atlanta, GA, 30329, USA.
Jonathan M GrundDivision of Global HIV and Tuberculosis, Centers for Disease Control and Prevention, Pretoria, South Africa.
Stephanie Davis, Tucson, USA.
Aisha YansanehOffice of HIV/AIDS, United States Agency for International Development (USAID), Washington, DC, USA.
Valerian L KiggunduOffice of HIV/AIDS, United States Agency for International Development (USAID), Washington, DC, USA.
Anne G ThomasHIV/AIDS Prevention Program U.S. Department of Defense, San Diego, CA, USA.
Kelly CurranJhpiego, Baltimore, MD, USA.
Catharine LaubeJhpiego, Baltimore, MD, USA.
Maaya SundaramGlobal Development Program, Bill & Melinda Gates Foundation, Seattle, WA, USA.
Wole AmeyanDepartment of HIV, Viral Hepatitis and STIs, World Health Organization, Geneva, Switzerland.
Lycias ZembeUnited Nations Joint Programme on HIV/AIDS, Geneva, Switzerland.
Carlos ToledoDivision of Global HIV and Tuberculosis, US Centers for Disease Control and Prevention, 3 Corporate Blvd NE, US1-1, Atlanta, GA, 30329, USA.
Centers for Disease Control and Prevention · USUnited States Agency for International Development · USBill & Melinda Gates Foundation · USEnvironmental Education Exchange · USJoint United Nations Programme on HIV/AIDS · CHUnited States Department of Defense · USWorld Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

purpose of reviewSince 2007, voluntary medical male circumcision (VMMC) programs have been associated with substantially reduced HIV incidence across 15 prioritized countries in Eastern and Southern Africa. Drawing on the programmatic experience of global VMMC leaders, this report reviews progress made in the first 15 years of the program, describes programmatic and research gaps, and presents considerations to maximize the impact of VMMC. RECENT

findingsOverall, key programmatic and research gaps include a lack of robust male circumcision coverage estimates due to limitations to the data and a lack of standardized approaches across programs; challenges enhancing VMMC uptake include difficulties reaching populations at higher risk for HIV infection and men 30 years and older; limitations to program and procedural quality and safety including variations in approaches used by programs; and lastly, sustainability with limited evidence-based practices. Considerations to address these gaps include the need for global guidance on estimating coverage, conducting additional research on specific sub-populations to improve VMMC uptake, implementation of responsive and comprehensive approaches to adverse event surveillance, and diversifying financing streams to progress towards sustainability. This report's findings may help establish a global VMMC research and programmatic agenda to inform policy, research, and capacity-building activities at the national and global levels.

Indexed as

Circumcision, MaleHIV InfectionsAfrica, SouthernHumansIncidenceMaleVoluntary ProgramsHIV/AIDSHIV preventionSub-Saharan AfricaVoluntary medical male circumcision

Identifiers

PMID36367637
PMCPMC9651117
OpenAlexW4308769189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.